NASDAQ:RXST

Rxsight Stock Insider Trading

Healthcare > Medical - Devices

Buy RXST

*Your capital is at risk

$6.01

-0.0700 (-1.15%)

At Close: Jul 31, 2026

RxSight Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.61. In total, the insiders bought 6.31M and sold 37.9K RXST shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	91.61
● Buy	6.31M shares
● Sell	37.9K shares
92% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jul 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 91.61. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 12, 2025 Sell	Common Stock S-Sale	Fountain Tamara Director	Director	7 000 Value: $180.0K
Mar 12, 2025 Sell	Common Stock S-Sale	Fountain Tamara Director	Director	7 000 Value: $180.0K
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Weinberg Eric See Remarks	Officer	125 000 Value: $3.53M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Goldshleger Ilya See Remarks	Officer	125 000 Value: $3.53M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Thunen Shelley B See Remarks	Officer	125 000 Value: $3.53M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Kurtz Ronald M Md President & CEO	CEO / President	215 000 Value: $6.07M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Kurtz Ronald M Md President & CEO	CEO / President	215 000 Value: $6.07M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Thunen Shelley B See Remarks	Officer	125 000 Value: $3.53M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Goldshleger Ilya See Remarks	Officer	125 000 Value: $3.53M
Feb 27, 2025 Buy	Stock Option (right to buy) A-Award	Weinberg Eric See Remarks	Officer	125 000 Value: $3.53M
Jan 22, 2025 Sell	Common Stock S-Sale	Maniar Shweta Director	Director	3 519 Value: $108.6K
Jan 22, 2025 Sell	Common Stock S-Sale	Maniar Shweta Director	Director	3 519 Value: $108.6K
Jan 16, 2025 Buy	Common Stock P-Purchase	Corley Jesse Anderson Director	Director	1 767 Value: $55.0K
Jan 16, 2025 Buy	Common Stock P-Purchase	Corley Jesse Anderson Director	Director	1 767 Value: $55.0K
Jan 15, 2025 Buy	Common Stock P-Purchase	Corley Jesse Anderson Director	Director	1 443 Value: $45.0K
Jan 15, 2025 Buy	Common Stock P-Purchase	Corley Jesse Anderson Director	Director	1 443 Value: $45.0K
Nov 29, 2024 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	3 105 Value: $46.8K
Nov 29, 2024 Sell	Common Stock S-Sale	Goldshleger Ilya See Remarks	Officer	3 105 Value: $143.1K
Nov 29, 2024 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	3 105 Value: $46.8K
Nov 29, 2024 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	3 105 Value: $46.8K
Nov 29, 2024 Sell	Common Stock S-Sale	Goldshleger Ilya See Remarks	Officer	3 105 Value: $143.1K
Nov 29, 2024 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	3 105 Value: $46.8K
Nov 26, 2024 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	3 100 Value: $46.7K
Nov 26, 2024 Buy	Common Stock M-Exempt	Goldshleger Ilya See Remarks	Officer	3 100 Value: $46.7K
Nov 22, 2024 Buy	Stock Option (right to buy) M-Exempt	Goldshleger Ilya See Remarks	Officer	3 100 Value: $46.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT RXSIGHT, INC.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment dev...

Read Full Profile Here